Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast Response by LTC4 Synthase Polymorphism
NCT00116324Phase 3Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Apr 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Montelukast with Placebo (2 arms). Primary endpoint: Change in hypertonic saline PD20. Started Apr 2003; status: completed.
02
Drugs
montelukast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00116324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00116324.